Termination of pseudopregnancy in the rat produces an anxiogenic-like response that is associated with an increase in benzodiazepine receptor binding density and a decrease in GABA-stimulated chloride influx in the hippocampus

Brain Research Bulletin

Volumn 64, Issue 6, 2005, Pages 511-518

  Bitran, Daniel ^a   Smith, Sheryl S ^b  

^a Department of Biology   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Allopregnanolone; Anxiety; Benzodiazepine receptor; Neurosteroid; Tolerance; Withdrawal

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR; BRAIN RECEPTOR; CHLORIDE; FLUNITRAZEPAM; STEROID; TRITIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BINDING ASSAY; BRAIN CORTEX; CEREBELLUM; CHLORIDE TRANSPORT; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; MAZE TEST; NEUROMODULATION; NONHUMAN; OVARIECTOMY; OVARY; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOPREGNANCY; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; STIMULATION; SYNAPSE;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANXIETY; CEREBRAL CORTEX; CHLORIDES; FEMALE; GAMMA-AMINOBUTYRIC ACID; GONADOTROPINS; GONADOTROPINS, EQUINE; HIPPOCAMPUS; HUMANS; ISOTOPES; MAZE LEARNING; OVARIECTOMY; PREGNANOLONE; PSEUDOPREGNANCY; RADIOIMMUNOASSAY; RADIOLIGAND ASSAY; RATS; RECEPTORS, GABA-A; STEROIDS; TIME FACTORS;

EID: 11444262722     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2004.11.001     Document Type: Article

References (36)

1. D. Belelli, M.B. Bolger, and K.W. Gee Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one Eur. J. Pharmacol. 166 1989 325 329
2. D. Bitran, M. Dugan, P. Renda, R. Ellis, and M. Foley Anxiolytic effects of the neuroactive steroid pregnanolone (3α-OH-5β-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum Brain Res. 850 1999 217 224
3. D. Bitran, M. Foley, D. Audette, N. Leslie, and C.A. Frye Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat Psychopharmacology 151 2000 64 71
4. A receptor Brain Res. 561 1991 157 161
5. A receptors J. Neuroendocrinol. 7 1995 171 177
6. D. Bitran, S.M. Solano, Pseudopregnancy in the rat decreases the anxiolytic-like effect of progesterone and chlordiazepoxide, but increases sensitivity to the anxiolytic-like effect of MK-801, Psychopharmacology, in press.
7. M.D. Brot, Y. Akwa, R.H. Purdy, G.F. Koob, and K.T. Britton The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAa receptors Eur. J. Pharmacol. 325 1997 1 7
8. E. Carbone, S. Wieland, N.C. Lan, and K.W. Gee Anxiolytic properties of endogenously occurring pregnanediols in two rodent models of anxiety Psychopharmacology 126 1996 173 178
9. D.J. Cash, P. Serfozo, and A.M. Allan Desensitization of a γ-aminobutyric acid type A receptor in rat is increased by chronic treatment with chlordiazepoxide: a molecular mechanism of dependence J. Pharmacol. Exp. Ther. 283 1997 704 711
10. Z. Chen, and K.M.J. Menon Expression of high density lipoprotein-binding protein messenger ribonucleic acid in the rat ovary and its regulation by gonadotropin Endocrinology 134 1994 2360 2366
11. A.-M.N. Costa, K.T. Spence, S.S. Smith, and J.M.H. ffRench-Mullen Withdrawal from the endogenous steroid progesterone results in GABAa currents insensitive to benzodiazepine modulation in rat CA1 hippocampus J. Neurophysiol. 74 1995 464 469
12. A.I. Czlonkowska, P. Krascik, H. Sienkiewicz-Jarosz, M. Siemiatkowski, J. Szyndler, P. Maciejak, A. Bidzinski, and A. Plaznik Tolerance to the anticonvulsant activity of midazolam and allopregnanolone in a model of picrotoxin seizures Eur. J. Pharmacol. 425 2001 121 127
13. L.L. Devaud, J. Fritschy, W. Sieghart, and A.L. Morrow Bidirectional alterations of GABAa receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal J. Neurochem. 69 1997 126 130
14. L.L. Devaud, R.H. Purdy, and A.L. Morrow The neurosteroid 3α-hydroxy-5α-pregnan-20-one protects against bicuculline-induced seizures during ethanol withdrawal in rats Alcohol. Clin. Exp. Res. 19 1995 350 355
15. A. Fernandez-Guasti, and O. Picazo Flumazenil blocks the anxiolytic action of allopregnanolone Eur. J. Pharmacol. 281 1995 113 115
16. C.A. Frye, and L.E. Bayon Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3α,5α-THP Neuroendocrinology 68 1998 272 280
17. M.A. Gallo, and S.S. Smith Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety Pharmacol. Biochem. Behav. 46 1993 897 904
18. M.A. Hutchinson, P.F. Smith, and C.L. Darlington The behavioral and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs Prog. Neurobiol. 49 1996 73 97
19. D.L. Lefebvre, R. Farookhi, A. Larcher, J. Neculcea, and H.H. Zingg Uterine oxytocin gene expression I. Induction during pseudopregnancy and the estrous cycle Endocrinology 134 1994 2556 2561
20. A receptor alpha4-subunit expression: possible relevance to alcohol dependence J. Neurochem. 68 1997 2485 2492
21. A receptor. Mechanism of action and physiological significance Prog. Neurobiol. 38 1992 379 395
22. F.H. Marshall, S.C. Stratton, J. Mullings, E. Ford, S.P. Worton, N.R. Oakley, and R.M. Hagan Development of tolerance in mice to the sedative effects of the neuroactive steroid minaxolone following chronic exposure Pharmacol. Biochem. Behav. 58 1997 1 8
23. W. Mayo, M. Vallee, M. Darnaudery, and M. Le Moal Neurosteroids: behavioral studies E.-E. Baulieu P. Robel M. Schumacher Neurosteroids: A New Regulatory Function in the Nervous System, vol. 21 1999 Humana Press Totowa, NJ 317 335
24. M.H. Moran, M. Goldberg, and S.S. Smith Progesterone withdrawal II: insensitivity to the sedative effects of a benzodiazepine Brain Res. 807 1998 91 100
25. M.H. Moran, and S.S. Smith Progesterone withdrawal I: pro-convulsant effects Brain Res. 807 1998 84 90
26. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J. Neurosci. Meth. 14 1985 149 167
27. R.H. Purdy, P.H.J. Moore, P.N. Rao, N. Hagino, T. Yamaguchi, P. Schmidt, D.R. Rubinow, A.L. Morrow, and S.M. Paul Radioimmunoassay of 3α-hydroxy-5α-pregnan-20-one in rat and human plasma Steroids 55 1990 290 296
28. M.A.E. Ramsey, T.M. Savege, B.R.J. Simpson, and R. Goodwin Controlled sedation with alphaxolone-alphadolone Br. Med. J. 2 1974 256 259
29. D.S. Reddy, and M.A. Rogawski Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself J. Pharmacol. Exp. Ther. 295 2000 1241 1248
30. D.S. Reddy, and M.A. Rogawski Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy J. Pharmacol. Exp. Ther. 294 2000 909 915
31. P. Robel, M. Schumacher, and E.-E. Baulieu Neurosteroids: from definition and biochemistry to physiopathologic function E.-E. Baulieu P. Robel M. Schumacher Neurosteroids: A New Regulatory Function in the Nervous System, vol. 21 1999 Humana Press Totowa, NJ 1 25
32. A Receptor 2003 CRC Press Boca Raton, FL 197 208
33. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid Nature 392 1998 926 930
34. A receptor α4 subunit in association with increased anxiety J. Neurosci. 18 1998 5275 5284
35. S. Wieland, J.D. Belluzzi, J.E. Hawkinson, D. Hogenkamp, R. Upasani, L. Stein, P.L. Wood, K.W. Gee, and N.C. Lan Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid, Co3-0593 Psychopharmacology 134 1997 46 54
36. I.H. Zwain, and S.S. Yen Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain Endocrinology 140 1999 3843 3852